ArticlePharmaceuticals (Basel, Switzerland)2023

Computational and Experimental Drug Repurposing of FDA-Approved Compounds Targeting the Cannabinoid Receptor CB1.

Emanuele Criscuolo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.